Pang Kee Chan Hebert - Net Worth and Insider Trading
Pang Kee Chan Hebert Net Worth
The estimated net worth of Pang Kee Chan Hebert is at least $1.2 Billion dollars as of 2024-09-23. Pang Kee Chan Hebert is the 2201 Interest of corporation controlled by you of InnoCare Pharma Ltd and owns about 158,588,612 shares of InnoCare Pharma Ltd (HKSE:09969) stock worth over $867 Million. Pang Kee Chan Hebert is the of Alphamab Oncology and owns about 49,691,190 shares of Alphamab Oncology (HKSE:09966) stock worth over $129 Million. Pang Kee Chan Hebert is also the of HBM Holdings Ltd and owns about 93,561,360 shares of HBM Holdings Ltd (HKSE:02142) stock worth over $114 Million. Besides these, Pang Kee Chan Hebert also holds TOT Biopharm International Co Ltd (HKSE:01875) . Details can be seen in Pang Kee Chan Hebert's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pang Kee Chan Hebert has not made any transactions after 2024-04-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pang Kee Chan Hebert
Pang Kee Chan Hebert Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pang Kee Chan Hebert owns 4 companies in total, including TOT Biopharm International Co Ltd (HKSE:01875) , Alphamab Oncology (HKSE:09966) , and InnoCare Pharma Ltd (HKSE:09969) among others .
Click here to see the complete history of Pang Kee Chan Hebert’s form 4 insider trades.
Insider Ownership Summary of Pang Kee Chan Hebert
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01875 | TOT Biopharm International Co Ltd | 2019-11-08 | |
| HKSE:09966 | Alphamab Oncology | 2019-12-12 | |
| HKSE:09969 | InnoCare Pharma Ltd | 2024-04-10 | 2201 Interest of corporation controlled by you |
 | | 2020-12-10 |
Pang Kee Chan Hebert Latest Holdings Summary
Pang Kee Chan Hebert currently owns a total of 4 stocks. Among these stocks, Pang Kee Chan Hebert owns 158,588,612 shares of InnoCare Pharma Ltd (HKSE:09969) as of April 10, 2024, with a value of $867 Million and a weighting of 71.78%. Pang Kee Chan Hebert owns 49,691,190 shares of Alphamab Oncology (HKSE:09966) as of December 12, 2019, with a value of $129 Million and a weighting of 10.65%. Pang Kee Chan Hebert also owns 93,561,360 shares of HBM Holdings Ltd (HKSE:02142) as of December 10, 2020, with a value of $114 Million and a weighting of 9.44%. The other 1 stocks TOT Biopharm International Co Ltd (HKSE:01875) have a combined weighting of 8.13% among all his current holdings.
Latest Holdings of Pang Kee Chan Hebert
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:09969 | InnoCare Pharma Ltd | 2024-04-10 | 158,588,612 | 5.47 | 867,479,708 |
| HKSE:09966 | Alphamab Oncology | 2019-12-12 | 49,691,190 | 2.59 | 128,700,182 |
| HKSE:02142 | HBM Holdings Ltd | 2020-12-10 | 93,561,360 | 1.22 | 114,144,859 |
| HKSE:01875 | TOT Biopharm International Co Ltd | 2019-11-08 | 49,136,800 | 2.00 | 98,273,600 |
Holding Weightings of Pang Kee Chan Hebert
Pang Kee Chan Hebert Form 4 Trading Tracker
According to the SEC Form 4 filings, Pang Kee Chan Hebert has made a total of 7 transactions in InnoCare Pharma Ltd (HKSE:09969) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in InnoCare Pharma Ltd is the sale of 56,000 shares on April 10, 2024, which brought Pang Kee Chan Hebert around $0.
According to the SEC Form 4 filings, Pang Kee Chan Hebert has made a total of 1 transactions in Alphamab Oncology (HKSE:09966) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Alphamab Oncology is the sale of 0 shares on December 12, 2019, which brought Pang Kee Chan Hebert around $0.
According to the SEC Form 4 filings, Pang Kee Chan Hebert has made a total of 1 transactions in HBM Holdings Ltd (HKSE:02142) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in HBM Holdings Ltd is the sale of 0 shares on December 10, 2020, which brought Pang Kee Chan Hebert around $0.
More details on Pang Kee Chan Hebert's insider transactions can be found in the Insider Trading History of Pang Kee Chan Hebert table.Insider Trading History of Pang Kee Chan Hebert
- 1
Pang Kee Chan Hebert Trading Performance
GuruFocus tracks the stock performance after each of Pang Kee Chan Hebert's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pang Kee Chan Hebert is 7.12%. GuruFocus also compares Pang Kee Chan Hebert's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pang Kee Chan Hebert within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pang Kee Chan Hebert's insider trading performs compared to the benchmark.
Performance of Pang Kee Chan Hebert
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.89 | | | | | |
| Relative Return to S&P 500(%) | 12.28 | | | | | |
Pang Kee Chan Hebert Ownership Network
Ownership Network List of Pang Kee Chan Hebert
Ownership Network Relation of Pang Kee Chan Hebert
Pang Kee Chan Hebert Owned Company Details
What does TOT Biopharm International Co Ltd do?
Who are the key executives at TOT Biopharm International Co Ltd?
Pang Kee Chan Hebert is the of TOT Biopharm International Co Ltd. Other key executives at TOT Biopharm International Co Ltd include 2201 Interest of corporation controlled by you Center Laboratories, Inc. , 2301 Trustee Tricor Trust (hong Kong) Limited , and 2101 Beneficial owner Chengwei Evergreen Capital, LP .
TOT Biopharm International Co Ltd (HKSE:01875) Insider Trades Summary
Over the past 18 months, Pang Kee Chan Hebert made no insider transaction in TOT Biopharm International Co Ltd (HKSE:01875). Other recent insider transactions involving TOT Biopharm International Co Ltd (HKSE:01875) include a net sale of 0 shares made by Center Laboratories, Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of TOT Biopharm International Co Ltd (HKSE:01875) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TOT Biopharm International Co Ltd (HKSE:01875) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
TOT Biopharm International Co Ltd (HKSE:01875)'s detailed insider trading history can be found in Insider Trading Tracker table.
TOT Biopharm International Co Ltd Insider Transactions
Pang Kee Chan Hebert Mailing Address
Above is the net worth, insider trading, and ownership report for Pang Kee Chan Hebert. Currently GuruFocus does not have mailing address information for Pang Kee Chan Hebert.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
